Skip to Main Content
TRC_PLH
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Diabetes Drugs
    • Do Not Crush List
    • IV Fluid Safety
    • New Drugs
    • Opioid Dosing
    • Vancomycin Dosing
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Become a smarter pharmacist in minutes! More CE, more resources, more value. Choose your Hospital Pharmacist's Letter membership and elevate your pharmacy practice today. Subscribe Now
  1. Home
  2. Browse
  3. Hematology & Oncology
  4. Breast Cancer
  5. Drug Toxicity
  6. Breast Cancer Risk
  7. Antipsychotics

Antipsychotics

  • Anemia (34)
  • Blood Products (10)
  • Breast Cancer (32)
    • Drug Toxicity (27)
      • Breast Cancer Risk (21)
        • Antibiotics (10)
        • Antipsychotics (6)
        • Hormone Therapies and Contraceptives (5)
      • Hot Flashes (6)
    • Natural Medicines/Supplements (1)
    • Prevention/Risk Factors (5)
    • Treatment (5)
  • Cancer (14)
  • Cervical Cancer (2)
  • Chemotherapy (5)
  • Chemotherapy-Induced Adverse Effects (19)
  • Colon Cancer (11)
  • Drugs/Products That May Increase Cancer Risk (72)
  • Gastrointestinal Cancers (17)
  • Hemophilia (6)
  • Hemorrhage (18)
  • Leukemia (1)
  • Lung Cancer (77)
  • Ovarian Cancer (2)
  • Prostate Cancer (10)
  • Resources (59)
  • Sepsis (2)
  • Sickle Cell Disease (4)
  • Skin Cancer (11)
1 - 6 of 6 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Clozapine REMS program updates/deadline extensions November 2015
Other: FDA Safety Communication Clozapine Shared REMS November 2015
Other: What’s New with Clozapine: An Overview November 2015
Commentary: Treatment-Resistant Depression September 2013
Commentary: New Formulation: Adasuve (Loxapine) Inhaler August 2013
Commentary: Combining Antipsychotics in Schizophrenia October 2012
  • 1
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved